Heavy investments and decades of work and effort are involved in pharmaceutical product development. Thus, to recover R&D costs and promote innovation pharmaceutical organizations protect their patents, until they reach the point of expiration. Patents provide intellectual property protection for every new pharmaceutical product, process, and/or indication. This ensures product exclusivity and return of investment for pharmaceutical organizations. DDReg combines industry knowledge and strategic insight to provide appropriate IPR support. We conduct in-depth review of patent landscape to identify parallel products and activities, including competitor patenting and help our customers to implement informed strategic patenting decisions. Our patent attorneys carry decades of experience in handling patents and intellectual property services and are well informed of IPR issues and obtaining patents in the intended global markets.
DDReg’s IPR support services include:
- Conducting in-depth analyses to determine product patent landscape for desired global markets
- Reviewing and assessing patent portfolios
- Providing IPR support for product development to ensure earliest product launch date
- Reviewing patent applications (covered by 505b(2) of the FDA) and investigating the expiry of a product’s exclusivity